Compstatins: the dawn of clinical C3-targeted complement inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Compstatins: the dawn of clinical C3-targeted complement inhibition

Published:2022-08 Issue:8 Volume:43 Page:629-640
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Lamers Christina,Mastellos Dimitrios C.,Ricklin Daniel,Lambris John D.^ORCID

Funder

Sanofi

Baxter International

National Institutes of Health

Viropharma

Alexion Pharmaceuticals

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Roche

Shire

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference65 articles.

1. Control of adaptive immunity by the innate immune system;Iwasaki;Nat. Immunol.,2015

2. New insights into the immune functions of complement;Reis;Nat. Rev. Immunol.,2019

3. Novel mechanisms and functions of complement;Hajishengallis;Nat. Immunol.,2017

4. A C3 (H2O) recycling pathway is a component of the intracellular complement system;Elvington;J. Clin. Invest.,2017

5. Structure and activation of C1, the complex initiating the classical pathway of the complement cascade;Mortensen;Proc. Natl. Acad. Sci. U. S. A.,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement‐targeted therapeutics: Are we there yet, or just getting started?;European Journal of Immunology;2024-09-12

2. The complement model disease paroxysmal nocturnal hemoglobinuria;European Journal of Immunology;2024-08-05

3. Mechanism of complement inhibition by a mosquito protein revealed through cryo-EM;Communications Biology;2024-05-27

4. Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseases;Annals of the Rheumatic Diseases;2024-05-03

5. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3